Diagnosis and management of choledocholithiasis in the golden age of imaging, endoscopy and laparoscopy
Biliary lithiasis is an endemic condition in both Western and Eastern countries, in some studies affecting 20% of the general population. In up to 20% of cases, gallbladder stones are associated with common bile duct stones(CBDS), which are asymptomatic in up to one half of cases. Despite the wide v...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 20; no. 37; pp. 13382 - 13401 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
07.10.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1007-9327 2219-2840 2219-2840 |
DOI | 10.3748/wjg.v20.i37.13382 |
Cover
Loading…
Summary: | Biliary lithiasis is an endemic condition in both Western and Eastern countries, in some studies affecting 20% of the general population. In up to 20% of cases, gallbladder stones are associated with common bile duct stones(CBDS), which are asymptomatic in up to one half of cases. Despite the wide variety of examinations and techniques available nowadays, two main open issues remain without a clear answer: how to cost-effectively diagnose CBDS and, when they are finally found, how to deal with them. CBDS diagnosis and management has radically changed over the last 30 years, following the dramatic diffusion of imaging, including endoscopic ultrasound(EUS) and magnetic resonance cholangiography(MRC), endoscopy and laparoscopy. Since accuracy, invasiveness, potential therapeutic use and costeffectiveness of imaging techniques used to identifyCBDS increase together in a parallel way, the concept of "risk of carrying CBDS" has become pivotal to identifying the most appropriate management of a specific patient in order to avoid the risk of "under-studying" by poor diagnostic work up or "over-studying" by excessively invasive examinations. The risk of carrying CBDS is deduced by symptoms, liver/pancreas serology and ultrasound. "Low risk" patients do not require further examination before laparoscopic cholecystectomy. Two main "philosophical approaches" face each other for patients with an "intermediate to high risk" of carrying CBDS: on one hand, the "laparoscopy-first" approach, which mainly relies on intraoperative cholangiography for diagnosis and laparoscopic common bile duct exploration for treatment, and, on the other hand, the "endoscopy-first" attitude, variously referring to MRC, EUS and/or endoscopic retrograde cholangiography for diagnosis and endoscopic sphincterotomy for management. Concerning CBDS diagnosis, intraoperative cholangiography, EUS and MRC are reported to have similar results. Regarding management, the recent literature seems to show better short and long term outcome of surgery in terms of retained stones and need for further procedures. Nevertheless, open surgery is invasive, whereas the laparoscopic common bile duct clearance is time consuming, technically demanding and involves dedicated instruments. Thus, although no consensus has been achieved and CBDS management seems more conditioned by the availability of instrumentation, personnel and skills than cost-effectiveness, endoscopic treatment is largely preferred worldwide. |
---|---|
Bibliography: | Renato Costi;Alessandro Gnocchi;Francesco Di Mario;Leopoldo Sarli;Dipartimento di Scienze Chirurgiche,Università di Parma,Azienda Ospedaliero-Universitaria di Parma;Dipartimento Materno Infantile,Unità Operativa di Gastroenterologia ed Endoscopia Digestiva,Azienda Ospedaliero-Universitaria di Parma;Dipartimento di Medicina Clinica e Sperimentale,Università di Parma,Azienda Ospedaliero-Universitaria di Parma ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Author contributions: Costi R and Sarli L designed the article; Gnocchi A and Sarli L collected the data; Costi R, Gnocchi A and Sarli L analysed the data; Costi R and Gnocchi A wrote the paper; Di Mario F and Sarli L reviewed the paper for important intellectual contribution; Di Mario F and Sarli L supervised. Correspondence to: Renato Costi, MD, PhD, FACS, Dipartimento di Scienze Chirurgiche, Università di Parma, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43100 Parma, Italy. renatocosti@hotmail.com Telephone: +39-335-8234285 Fax: +39-521-940125 |
ISSN: | 1007-9327 2219-2840 2219-2840 |
DOI: | 10.3748/wjg.v20.i37.13382 |